References
- Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014 Jan-Feb; 64(1):9-29; PMID: 24399786; http://dx.doi.org/10.3322/caac.21208
- Yang KR, Mooney S, Zarif JC, Coffey DS, Taichman RS, Pienta KJ. Niche inheritance: a cooperative pathway to enhance cancer cell fitness through ecosystem engineering. J Cell Biochem 2014 Sep; 115(9):1478-85; http://dx.doi.org/10.1002/jcb.24813
- Camacho DF, Pienta KJ. Disrupting the networks of cancer. Clin Cancer Res 2012 May 15; 18(10):2801-8; PMID: 22442061; http://dx.doi.org/10.1158/1078-0432.CCR-12-0366
- Vinogradov S, Warren G, Wei X. Macrophages associated with tumors as potential targets and therapeutic intermediates. Nanomedicine (Lond) 2014 Apr; 9(5):695-707; PMID: 24827844; http://dx.doi.org/10.2217/nnm.14.13
- Cook J, Hagemann T. Tumour-associated macrophages and cancer. Curr Opin Pharmacol 2013 Aug; 13(4):595-601; PMID: 23773801; http://dx.doi.org/10.1016/j.coph.2013.05.017
- Tang X, Mo C, Wang Y, Wei D, Xiao H. Anti-tumour strategies aiming to target tumour-associated macrophages. Immunology. 2013 Feb; 138(2):93-104; PMID: 23113570; http://dx.doi.org/10.1111/imm.12023
- De Palma M, Lewis CE. Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell 2013 Mar 18; 23(3):277-86; PMID: 23518347; http://dx.doi.org/10.1016/j.ccr.2013.02.013.
- Roca H, Varsos ZS, Sud S, Craig MJ, Ying C, Pienta KJ. CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization. J Biol Chem 2009 Dec 4; 284(49):34342-54; PMID: 19833726; http://dx.doi.org/10.1074/jbc.M109.042671
- Loberg RD, Ying C, Craig M, Day LL, Sargent E, Neeley C, Wojno K, Snyder LA, Yan L, Pienta KJ. Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo. Cancer Res 2007 Oct 1; 67(19):9417-24; PMID: 17909051; http://dx.doi.org/10.1158/0008-5472.CAN-07-1286
- Roca H, Hernandez J, Weidner S, McEachin RC, Fuller D, Sud S, Schumann T, Wilkinson JE, Zaslavsky A, Li H, et al. Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer. PLoS One 2013 Oct 4; 8(10):e76773; PMID: 24124593; http://dx.doi.org/10.1371/journal.pone.0076773